Clinical utility of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography-related procedures

doi:10.4253/wjge.v9.i2.77

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6304)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

430

WORD

279

HTML

3135

Figures (1-5)

254

Tables (1-5)

168

Sum=4266

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

776

Download

1262

Sum=2038

Feb 16, 2017 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastrointest Endosc. Feb 16, 2017; 9(2): 77-84
Published online Feb 16, 2017. doi: 10.4253/wjge.v9.i2.77

Table 3 Papillary treatment

	VisiGlide2^TM		VisiGlide^TM
Papillary treatment	n	Success rate of procedure	n	Success rate of procedure	P-value
EST	67	100 (67/67)%	67	100 (67/67)%	NS
EST + EPLBD	3	100 (3/3)%	5	100 (5/5)%	NS
EPST	3	100 (3/3)%	3	100 (3/3)%	NS
EPBD	1	100 (1/1)%	4	100 (4/4)%	NS
Total	74	100 (74/74)%	79	100 (79/79)%	NS

EST: Endoscopic sphincterotomy; EPLBD: Endoscopic papillary large balloon dilation; EPST: Endoscopic pancreatic sphincterotomy; EPBD: Endoscopic papillary balloon dilation; NS: Not significant.

Citation: Sakai Y, Tsuyuguchi T, Hirata N, Nakaji S, Shimura K, Nishikawa T, Fujimoto T, Hamano T, Nishino T, Yokosuka O. Clinical utility of 0.025-inch guidewire VisiGlide2^TM in the endoscopic retrograde cholangiopancreatography-related procedures. World J Gastrointest Endosc 2017; 9(2): 77-84
URL: https://www.wjgnet.com/1948-5190/full/v9/i2/77.htm
DOI: https://dx.doi.org/10.4253/wjge.v9.i2.77